Opis działalności
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk markets its products in more than 180 countries.
Zarząd & Rada nadzorcza
| CEO |
| Lars Fruergaard Jørgensen |
| Zarząd |
| Karsten Munk Knudsen, Camilla Sylvest, Doug Langa, Henrik Wulff, Ludovic Helfgott, Marcus Schindler, Martin Horst Lange, Maziar Mike Doustdar, Monique Carter, David Moore |
| Rada nadzorcza |
| Helge Lund, Andreas Fibig, Henrik Poulsen, Kasim Kutay, Laurence Debroux, Martin Mackay, Mette Bøjer Jensen, Sylvie Grégoire, Thomas Rantzau, Elisabeth Dahl Christensen, Liselotte Hyveled, Christina Law |
Dane firmy
| Nazwa: |
Novo Nordisk AS |
| Adres: |
Novo Allé,DK-2880 Bagsværd |
| Telefon: |
+45-4444-8888 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.novonordisk.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
66,64% |
| Data IPO: |
- |
